IAG Wealth Partners’s Gilead Sciences GILD Stock Holding History

IAG Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-39	Closed	-$2.68K	–	506
2024 Q2	$2.68K	Buy	+39	New	+$2.6K	﹤0.01%	435
2023 Q4	–	Sell	-81	Closed	-$6.07K	–	445
2023 Q3	$6.07K	Buy	+81	New	+$6.23K	﹤0.01%	352
2023 Q1	–	Sell	-196	Closed	-$16.8K	–	467
2022 Q4	$16.8K	Hold	196	–	–	0.01%	234
2022 Q3	$12K	Hold	196	–	–	﹤0.01%	254
2022 Q2	$12K	Hold	196	–	–	﹤0.01%	258
2022 Q1	$12K	Hold	196	–	–	﹤0.01%	280
2021 Q4	$14K	Hold	196	–	–	﹤0.01%	260
2021 Q3	$14K	Sell	196 -238	-55%	-$16.7K	0.01%	227
2021 Q2	$30K	Buy	434 +2	+0.5%	+$134	0.01%	162
2021 Q1	$28K	Buy	432 +3	+0.7%	+$193	0.01%	157
2020 Q4	$25K	Buy	429 +2	+0.5%	+$121	0.01%	148
2020 Q3	$27K	Buy	427 +3	+0.7%	+$208	0.01%	137
2020 Q2	$33K	Buy	424 +2	+0.5%	+$153	0.02%	126
2020 Q1	$32K	Buy	422 +2	+0.5%	+$138	0.02%	119
2019 Q4	$28K	Buy	+420	New	+$27.4K	0.02%	151

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

IAG Wealth Partners's GILD Position: Q3 2024 in Review

IAG Wealth Partners sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 39 shares — an estimated $2.68K sold.

IAG Wealth Partners first reported a position in GILD in Q4 2019 and held it in 15 quarters. The position peaked at $33K in Q2 2020. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

IAG Wealth Partners reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
IAG Wealth Partners sold 39 Gilead Sciences shares in Q3 2024, an estimated $2.68K.
IAG Wealth Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 15 quarters.
IAG Wealth Partners's Gilead Sciences position peaked at $33K in Q2 2020.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on IAG Wealth Partners's 13F filing for Q3 2024, filed 29 Oct 2024.